Modeling data show Cologuard Plus TM test delivers highest life-years gained with fewest number of colonoscopies among noninvasive colorectal cancer (CRC) screening strategies Additional abstracts ...

ACG abstracts are available on the meeting website. “Exact Sciences is pleased to share new modeling data which demonstrates the Cologuard Plus test as an efficient CRC screening strategy across ...

Cologuard causes more false alarms than FIT ... If you decide to use home colon cancer testing, it's important to follow the instructions and discuss the next steps with your doctor.

The FDA has approved the Cologuard Plus test for colorectal cancer screening in adults aged 45 years at average risk for colorectal cancer. The Food and Drug Administration (FDA) has approved the ...

The stoma and the surrounding skin (peristomal skin) will require special care. Instructions are typically given to patients post-surgery by an enterostomal therapy (ET) nurse. Who Needs a Colostomy?

You will need a prescription from your healthcare provider to get a Cologuard kit. The kit will be shipped directly to your home and includes a larger collection container, a smaller specimen tube, a ...

Delayed reporting of cancer diagnosis by registries probably led to the weaker-than-expected effects of screening colonoscopy in preventing colorectal cancer (CRC) observed in the NordICC trial ...

Exact Sciences EXAS recently received FDA approval for its next-generation multitarget stool DNA test, Cologuard Plus. This marks a significant advancement for the company in the field of ...

The endorsement follows the recent approval by the FDA of Cologuard Plus, Exact Sciences' enhanced stool test for colorectal cancer screening. The approval, which was anticipated by both the analyst ...

Mark Massaro has given his Buy rating due to a combination of factors including the recent FDA approval and anticipated superior performance of Exact Sciences’ Cologuard Plus test. The analyst ...

Cologuard Plus™ test raises the performance bar with sensitivities of 95% for colorectal cancer and 43% for advanced precancerous lesions at 94% specificity Cologuard Plus test will minimize ...